Site Menu

Home

NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: RNJ19; congenital nephrotic syndrome mutation
NIH Registration Number: 0126
NIH Approval Number: NIHhESC-11-0126
Available for Distribution: Yes
Provider Restrictions: No Restrictions

Additional Information: This cell line was derived from an embryo that definitively carried the maternal mutation for congenital nephrotic syndrome; however, the status of the paternal mutation is unknown. The line could be either a compound heterozygote (positive for both the maternal and paternal mutations), or a simple heterozygote (positive for the maternal mutation and negative for the paternal mutation).

NIH Restrictions: NIH-funded research with this line is limited to research consistent with the following language from the informed consent document: "...characterization of stem cells from embryos discarded due to genetic defects or other abnormalities and the development of new methods for transforming stem cells into other cell types."

Submitting Organization: Reprogenetics, LLC
Provider Name: Reprogenetics, LLC
Provider Phone: 9733225043
Provider Email: mina.alikani@embryos.net
Provider URL:  
Approval Date: 06/16/2011


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

    • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on August 24, 2019 
Content Manager: hescregistry@mail.nih.gov 
Technical Issues: E-mail OER Webmaster